Results 251 to 260 of about 168,749 (376)

Transient ischemic attack caused by cerebral ergotism

open access: yesArquivos de Neuro-Psiquiatria, 2015
Gustavo Andrés Gaye Saavedra   +3 more
doaj   +1 more source

Limb-Shaking Transient Ischemic Attack Induced by Middle Cerebral Artery Stenosis [PDF]

open access: bronze, 2006
Weijian Jiang   +4 more
openalex   +1 more source

A multicentre registry of hospitalized patients with acute and chronic heart failure: Study design of the H2‐registry

open access: yesESC Heart Failure, EarlyView.
The H2‐Registry: overview, first results and outlook. Abstract Aims Heart failure (HF) is a highly prevalent condition affecting 1–3% of the adult population in Europe. Despite landmark improvements in HF care over the last two decades, hospitalization and mortality rates remain relatively high.
Johannes Leiner   +15 more
wiley   +1 more source

Physical activity modification following a Transient Ischemic Attack in individuals with diabetes. [PDF]

open access: yesCardiovasc Diabetol
Mavridis A   +3 more
europepmc   +1 more source

Cerebral Microhemorrhages Predict New Disabling or Fatal Strokes in Patients With Acute Ischemic Stroke or Transient Ischemic Attack [PDF]

open access: bronze, 2006
Jean-Martin Boulanger   +8 more
openalex   +1 more source

Early occurrence of heart failure hospitalization or ventricular arrhythmia re‐define the long‐term prognosis after CRT

open access: yesESC Heart Failure, EarlyView.
Abstract Aims Classifying patients as responders or non‐responders to cardiac resynchronization therapy (CRT) has been recently challenged, suggesting that preventing heart failure (HF) progression may also provide survival benefits. We assessed a novel classification based on echocardiographic left ventricular (LV) reverse remodelling and the ...
Anna Zsofia Toth   +8 more
wiley   +1 more source

Immune Checkpoint Inhibitors and Cardiovascular Adverse Events

open access: yesESC Heart Failure, EarlyView.
Abstract In the last years, we assisted to a tremendous increase in therapeutic options for the management of cancers, with immunotherapy at the forefront of this innovation. Immune checkpoint inhibitors (ICIs) have been developed to enhance the activity of the immune system against cancer cells (1) and the number of approvals for ICIs has rapidly ...
Maria Luisa De Perna   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy